“Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer”. 2026. Annual Methodological Archive Research Review 4 (3): 985-1101. https://doi.org/10.66021/.